Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy.
PURPOSE: This interventional, non-comparative case series assessed the outcome of intravitreal pan-anti-vascular endothelial growth factor (VEGF) agents in eyes with persistent or reactivated choroidal neovascularisation (CNV) following previous treatment with photodynamic therapy (PDT). METHODS: B...
Main Authors: | Jyothi, S, Chowdhury, H, Chong, V, Sivaprasad, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Polypoidal Choroidal Vasculopathy Treatment: Photodynamic Therapy, Anti-VEGF Monotherapy or Combination. Review of Clinical Studies
by: E. K. Pedanova, et al.
Published: (2019-06-01) -
Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation
by: Jorge González-Zamora, et al.
Published: (2022-06-01) -
Efficacy of combined use of anti-VEGF (Aflibercept) and lasercoagulation for corneal neovascularisation before keratoplasty
by: V. R. Mamikonyan, et al.
Published: (2018-12-01) -
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
by: Chakravarthy, U, et al.
Published: (2013) -
Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review
by: Arthur Baston, et al.
Published: (2021-05-01)